134 related articles for article (PubMed ID: 38843479)
21. Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines.
Munzone E; Bagnardi V; Campennì G; Mazzocco K; Pagan E; Tramacere A; Masiero M; Iorfida M; Mazza M; Montagna E; Cancello G; Bianco N; Palazzo A; Cardillo A; Dellapasqua S; Sangalli C; Pettini G; Pravettoni G; Colleoni M; Veronesi P
Br J Cancer; 2019 Aug; 121(4):325-331. PubMed ID: 31303642
[TBL] [Abstract][Full Text] [Related]
22. Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study.
Kang D; Kim IR; Choi EK; Im YH; Park YH; Ahn JS; Lee JE; Nam SJ; Lee HK; Park JH; Lee DY; Lacouture ME; Guallar E; Cho J
Oncologist; 2019 Mar; 24(3):414-420. PubMed ID: 30120165
[TBL] [Abstract][Full Text] [Related]
23. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
Eur J Oncol Nurs; 2013 Oct; 17(5):536-40. PubMed ID: 23571182
[TBL] [Abstract][Full Text] [Related]
24. Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT).
Kang D; Kim IR; Park YH; Im YH; Zhao D; Guallar E; Ahn JS; Cho J
Support Care Cancer; 2020 Apr; 28(4):1829-1837. PubMed ID: 31338640
[TBL] [Abstract][Full Text] [Related]
25. Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer - clinical evaluation of sensor-controlled scalp cooling.
Friedrichs K; Carstensen MH
Springerplus; 2014; 3():500. PubMed ID: 25279292
[TBL] [Abstract][Full Text] [Related]
26. Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy.
Vasconcelos I; Wiesske A; Schoenegg W
Breast; 2018 Aug; 40():1-3. PubMed ID: 29660543
[TBL] [Abstract][Full Text] [Related]
27. Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
Ohsumi S; Kiyoto S; Takahashi M; Hara F; Takashima S; Aogi K; Matsuda M; Yamamura N; Doi M
Support Care Cancer; 2021 Jan; 29(1):437-443. PubMed ID: 32388615
[TBL] [Abstract][Full Text] [Related]
28. Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.
Komen MM; Breed WP; Smorenburg CH; van der Ploeg T; Goey SH; van der Hoeven JJ; Nortier JW; van den Hurk CJ
Support Care Cancer; 2016 Jun; 24(6):2735-41. PubMed ID: 26805558
[TBL] [Abstract][Full Text] [Related]
29. The Efficacy of Paxman Scalp Cooling System in Preventing Hair Loss in Breast Cancer Patients Receiving Chemotherapy in Western India - Multi-centre Retrospective Cohort Study.
Mekha M; Joshi A; Maniar V; Maheshwari U; Joshi K; Kalaskar P; Sheth S; Kendre P; Morzaria D; Korgavkar R; Pethe C; Dhande S
Indian J Dermatol; 2024; 69(1):16-23. PubMed ID: 38572038
[TBL] [Abstract][Full Text] [Related]
30. Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: a review of controlled clinical trials.
Shah VV; Wikramanayake TC; DelCanto GM; van den Hurk C; Wu S; Lacouture ME; Jimenez JJ
J Eur Acad Dermatol Venereol; 2018 May; 32(5):720-734. PubMed ID: 28976026
[TBL] [Abstract][Full Text] [Related]
31. A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.
Dunnill CJ; Al-Tameemi W; Collett A; Haslam IS; Georgopoulos NT
Oncologist; 2018 Jan; 23(1):84-96. PubMed ID: 28951499
[TBL] [Abstract][Full Text] [Related]
32. The effect of a helmet type, home-use low-level light therapy device for chemotherapy-induced alopecia: study protocol for a randomized controlled trial.
Wu CX; Li CH; Shiao YH; Cheng HY; Wu TH; Lee CH; Chang ZY; Yeh YC
Trials; 2023 Dec; 24(1):789. PubMed ID: 38053197
[TBL] [Abstract][Full Text] [Related]
33. The Influence of Various Parameters on the Success of Sensor-Controlled Scalp Cooling in Preventing Chemotherapy-Induced Alopecia.
Schaffrin-Nabe D; Schmitz I; Josten-Nabe A; von Hehn U; Voigtmann R
Oncol Res Treat; 2015; 38(10):489-95. PubMed ID: 26451590
[TBL] [Abstract][Full Text] [Related]
34. Improving Information Provision on Chemotherapy-Induced Alopecia and Scalp Cooling: A Comprehensive Approach Including A Website and Web-Based Decision Tool.
van den Hurk C; Keizer-Heldens P; Raats I; Hoeijmakers K; Mols F
Asia Pac J Oncol Nurs; 2019; 6(4):336-342. PubMed ID: 31572752
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of scalp cooling for prevention of chemotherapy induced alopecia: a systematic review and meta-analysis.
Shen XF; Ru LX; Yao XB
Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5090-5103. PubMed ID: 34486683
[TBL] [Abstract][Full Text] [Related]
36. Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations.
Mols F; van den Hurk CJ; Vingerhoets AJ; Breed WP
Support Care Cancer; 2009 Feb; 17(2):181-9. PubMed ID: 18560904
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy and Safety of Scalp Cooling Device RV21-01 for Suppression of Chemotherapy-Induced Alopecia in Breast Cancer Patients].
Nomizu T; Ueo H; Kato M; Fukuma E
Gan To Kagaku Ryoho; 2023 Mar; 50(3):321-325. PubMed ID: 36927900
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
Protière C; Evans K; Camerlo J; d'Ingrado MP; Macquart-Moulin G; Viens P; Maraninchi D; Genre D
Support Care Cancer; 2002 Oct; 10(7):529-37. PubMed ID: 12324807
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study.
Kate S; Patil R; Pathan D; Vyavhare R; Joseph S; Baby V; Ramesh YV; Nagarkar R
Cancer Treat Res Commun; 2021; 26():100280. PubMed ID: 33338853
[TBL] [Abstract][Full Text] [Related]
40. Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
Carbognin L; Accetta C; Di Giorgio D; Fuso P; Muratore M; Tiberi G; Pavese F; D'Angelo T; Fabi A; Giannarelli D; Di Leone A; Magno S; Garganese G; Sanchez AM; Terribile DA; Franceschini G; Masetti R; Scambia G; Paris I
Curr Oncol; 2022 Sep; 29(10):7218-7228. PubMed ID: 36290846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
